Graphene brain sensor tested in humans for first time
NCT ID NCT06368310
First seen Jun 24, 2026 · Last updated Jul 01, 2026 · Updated 4 times
Summary
This study tests a new graphene-based electrode array used during brain tumor surgery to map brain activity. Ten participants will have the device used alongside standard monitoring to check its safety and how well it records brain signals. If awake during surgery, they may do simple tasks to help decode brain signals. The goal is to see if this technology is safe and effective for future use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Graphene Cortical Interface (device)
What this could lead to
If successful, this could pave the way for safer, higher-quality brain mapping during surgery, potentially improving outcomes for brain tumor patients.
What could go wrong
This is a very early, small trial (10 people) focused on safety, not treatment. The device may not work as hoped, and risks include surgical complications or poor signal quality.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust
Salford, Greater Manchester, M6 8HD, United Kingdom